PuSH - Publication Server of Helmholtz Zentrum München: Spectrum and prevalence of mutations involving BrS1- through BrS12-susceptibility genes in a cohort of unrelated patients referred for Brugada Syndrome genetic testing: Implications for genetic testing.

Navigation

Home

Deutsch

Research

Advanced Search

Browse by ...

... Journal

... Publication Type

... Research Data

... Publication Year

Publication overview

Support & Contact

Contact persons

Help

Data protection

Crotti, L. ; Marcou, C.A.* ; Tester, D.J.* ; Castelletti, S.* ; Giudicessi, J.R.* ; Torchio, M.* ; Medeiros-Domingo, A.* ; Simone, S.* ; Will, M.L.* ; Dagradi, F.* ; Schwartz, P.J.* ; Ackerman, M.J.*

Spectrum and prevalence of mutations involving BrS1- through BrS12-susceptibility genes in a cohort of unrelated patients referred for Brugada Syndrome genetic testing: Implications for genetic testing.

J. Am. Coll. Cardiol. 60, 1410-1418 (2012)

DOI

PMC

Open Access Green as soon as Postprint is submitted to ZB.

Abstract
Metrics
Extra information

Objectives The aim of this study was to provide the spectrum and prevalence of mutations in the 12 Brugada syndrome (BrS)-susceptibility genes discovered to date in a single large cohort of unrelated BrS patients. Background BrS is a potentially lethal heritable arrhythmia syndrome diagnosed electrocardiographically by coved-type ST-segment elevation in the right precordial leads (V-1 to V-3; type 1 Brugada electrocardiographic [ECG] pattern) and the presence of a personal/family history of cardiac events. Methods Using polymerase chain reaction, denaturing high-performance liquid chromatography, and DNA sequencing, comprehensive mutational analysis of BrS1-through BrS12-susceptibility genes was performed in 129 unrelated patients with possible/probable BrS (46 with clinically diagnosed BrS [ECG pattern plus personal/family history of a cardiac event] and 83 with a type 1 BrS ECG pattern only). Results Overall, 27 patients (21%) had a putative pathogenic mutation, absent in 1,400 Caucasian reference alleles, including 21 patients with an SCN5A mutation, 2 with a CACNB2B mutation, and 1 each with a KCNJ8 mutation, a KCND3 mutation, an SCN1Bb mutation, and an HCN4 mutation. The overall mutation yield was 23% in the type 1 BrS ECG pattern-only patients versus 17% in the clinically diagnosed BrS patients and was significantly greater among young men <20 years of age with clinically diagnosed BrS and among patients who had a prolonged PQ interval. Conclusions We identified putative pathogenic mutations in similar to 20% of our BrS cohort, with BrS genes 2 through 12 accounting for <5%. Importantly, the yield was similar between patients with only a type 1 BrS ECG pattern and those with clinically established BrS. The yield approaches 40% for SCN5A-mediated BrS (BrS1) when the PQ interval exceeds 200 ms. Calcium channel-mediated BrS is extremely unlikely in the absence of a short QT interval.

Altmetric

Additional Metrics?

[➜Log in]

Edit extra informations Login

Publication type Article: Journal article

Document type Scientific Article

Corresponding Author

Keywords Brugada Syndrome ; Cardiac Arrest ; Genetic Testing ; St-segment Elevation ; Ventricular Arrhythmias; SUDDEN CARDIAC DEATH; ST-SEGMENT ELEVATION; BUNDLE-BRANCH BLOCK; J-WAVE SYNDROMES; QT-SYNDROME; CHANNEL VARIANTS; ARRHYTHMIAS; SUSCEPTIBILITY; CHANNELOPATHIES; MODULATION

ISSN (print) / ISBN 0735-1097

e-ISSN 1558-3597

Journal Journal of the American College of Cardiology

Quellenangaben Volume: 60, Issue: 15, Pages: 1410-1418

Publisher Elsevier

Publishing Place New York, NY

Non-patent literature Publications

Reviewing status Peer reviewed

Institute(s) Institute of Human Genetics (IHG)